What is the address of MED@ CONSULTING?

The registered office of MED@ CONSULTING is located at C-Mine 12, 3600 Genk.

Is MED@ CONSULTING still active?

Yes. According to the CBE (31 October 2026) MED@ CONSULTING is active, legal situation “Normale toestand”, started on 28 June 2005.

Is MED@ CONSULTING registered on Peppol?

Yes, MED@ CONSULTING is registered on the Peppol network with ID 0208:0874719076.

What is the enterprise number of MED@ CONSULTING?

The enterprise number of MED@ CONSULTING is BE0874719076.

When was MED@ CONSULTING founded?

MED@ CONSULTING was founded on 28 June 2005.

Who are the directors of MED@ CONSULTING?

According to the 2025 annual accounts, the directors of MED@ CONSULTING are: Ruben Dondeyne.

Is MED@ CONSULTING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 June 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MED@ CONSULTING make in 2025?

MED@ CONSULTING posted a profit after taxes of € 238,824 in financial year 2025.

What is the revenue of MED@ CONSULTING?

As a small company, MED@ CONSULTING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 400,135.

MED@ CONSULTING (Private Limited) - Genk - BE0874719076

Q: What does MED@ CONSULTING do?

MED@ CONSULTING is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van public relations en communicatie. Private Limited, started on 28 June 2005, 1 establishment.

Dossier MED@ CONSULTING, printed on 31 October 2026 from databakkes.be/en/0874719076/med-consulting. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

27 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

MED@ CONSULTING from Genk, company number BE0874719076, closed financial year 2025 with a result of € 238,824 after tax. For that financial year MED@ CONSULTING recorded a gross margin of € 400,135 and equity of € 422,872. Compared with financial year 2024, the result moved from € 66,059 to € 238,824. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Healthy

€ 422,872

▼ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 238,824

▲ 262% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 394,603

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 411,563 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 52,636

▲ 6% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 17,147

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 11,146

▼ 46% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 112,923

▼ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 183,143

▲ 203% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 157,992 Gross margin 2022: € 157,992 First fiscal year in the series	€ 188,424 Gross margin 2023: € 188,424 ▲ 19% vs 2022 (€ 157,992) Favourable step	€ 175,166 Gross margin 2024: € 175,166 ▼ 7% vs 2023 (€ 188,424) Unfavourable step	€ 400,135 Gross margin 2025: € 400,135 ▲ 128% vs 2024 (€ 175,166) Favourable step	▲ 128%
Profit after taxes	€ 80,026 Profit after taxes 2022: € 80,026 First fiscal year in the series	€ 109,929 Profit after taxes 2023: € 109,929 ▲ 37% vs 2022 (€ 80,026) Favourable step	€ 66,059 Profit after taxes 2024: € 66,059 ▼ 40% vs 2023 (€ 109,929) Unfavourable step	€ 238,824 Profit after taxes 2025: € 238,824 ▲ 262% vs 2024 (€ 66,059) Favourable step	▲ 262%
Equity	€ 565,451 Equity 2022: € 565,451 First fiscal year in the series	€ 675,380 Equity 2023: € 675,380 ▲ 19% vs 2022 (€ 565,451) Favourable step	€ 595,611 Equity 2024: € 595,611 ▼ 12% vs 2023 (€ 675,380) Unfavourable step	€ 422,872 Equity 2025: € 422,872 ▼ 29% vs 2024 (€ 595,611) Unfavourable step	▼ 29%
Total debts	€ 417,072 Total debts 2022: € 417,072 First fiscal year in the series	€ 548,637 Total debts 2023: € 548,637 ▲ 32% vs 2022 (€ 417,072) Unfavourable step	€ 439,963 Total debts 2024: € 439,963 ▼ 20% vs 2023 (€ 548,637) Favourable step	€ 821,567 Total debts 2025: € 821,567 ▲ 87% vs 2024 (€ 439,963) Unfavourable step	▲ 87%
Cash	€ 306,677 Cash 2022: € 306,677 First fiscal year in the series	€ 566,203 Cash 2023: € 566,203 ▲ 85% vs 2022 (€ 306,677) Favourable step	€ 388,750 Cash 2024: € 388,750 ▼ 31% vs 2023 (€ 566,203) Unfavourable step	€ 394,603 Cash 2025: € 394,603 ▲ 2% vs 2024 (€ 388,750) Favourable step	▲ 2%
Retained profit	€ 559,251 Retained profit 2022: € 559,251 First fiscal year in the series	€ 669,180 Retained profit 2023: € 669,180 ▲ 20% vs 2022 (€ 559,251) Favourable step	€ 589,411 Retained profit 2024: € 589,411 ▼ 12% vs 2023 (€ 669,180) Unfavourable step	€ 416,672 Retained profit 2025: € 416,672 ▼ 29% vs 2024 (€ 589,411) Unfavourable step	▼ 29%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 145,828 Dividend 2024: € 145,828 Unchanged (€ 0) Unchanged	€ 411,563 Dividend 2025: € 411,563 ▲ 182% vs 2024 (€ 145,828) Unchanged	▲ 182%
Bank debt	€ 34,922 Bank debt 2022: € 34,922 First fiscal year in the series	€ 20,554 Bank debt 2023: € 20,554 ▼ 41% vs 2022 (€ 34,922) Favourable step	€ 20,479 Bank debt 2024: € 20,479 Unchanged (€ 20,554) Favourable step	€ 11,146 Bank debt 2025: € 11,146 ▼ 46% vs 2024 (€ 20,479) Favourable step	▼ 46%
Balance sheet total	€ 982,523 Balance sheet total 2022: € 982,523 First fiscal year in the series	€ 1,224,016 Balance sheet total 2023: € 1,224,016 ▲ 25% vs 2022 (€ 982,523) Unchanged	€ 1,035,574 Balance sheet total 2024: € 1,035,574 ▼ 15% vs 2023 (€ 1,224,016) Unchanged	€ 1,244,439 Balance sheet total 2025: € 1,244,439 ▲ 20% vs 2024 (€ 1,035,574) Unchanged	▲ 20%
Employees (FTE)	0.9 Employees (FTE) 2022: 0.9 First fiscal year in the series	0.9 Employees (FTE) 2023: 0.9 Unchanged (0.9) Unchanged	-	-

Key figures of MED@ CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MED@ CONSULTING?

What happened at MED@ CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 238,824 (▲ 262% vs 2024). filed late Source: NBB ↗
Nov 1, 2018 New establishment in Genk. KBO
Jun 28, 2005 Start of the company according to the CBE. KBO

In short

From € 80,026 profit in 2022 to € 238,824 profit in 2025.

Paid € 214,806 in corporate taxes since 2022.

Best year ever: 2025, with € 238,824 profit.

Paid out € 557,391 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Ruben Dondeyne

MED@ CONSULTING

Behind MED@ CONSULTING is Ruben Dondeyne.

Directors

According to the 2025 annual accounts

Ruben Dondeyne

Director

Establishments

Establishment units

Physical locations of this company

Registered office

C-Mine 12

3600 Genk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 27 companies are registered at this address.

All companies at this address →

IMPULS

€ 1.4 million gross margin · 2025

King Arthur

€ 83,112 gross margin · 2025

MECHFIT

€ 234,263 gross margin · 2025

WALKING THE DOG

€ 1.9 million gross margin · 2025

MOOZE WEST

€ 251,283 gross margin · 2025

+22 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0874.719.076

VAT number

BE 0874.719.076

Registered office

C-Mine 12, 3600 Genk

Names & denominations

MED@ CONSULTING

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 June 2005

Peppol

Active · Active since 21 Nov 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Markt- en opinieonderzoek

Marktonderzoekbureaus

Adviesbureaus op het gebied van public relations en communicatie

Administratieve en ondersteunende activiteiten ten behoeve van kantoren

Activiteiten van reclamebureaus

Publiciteitsagentschappen

Overige activiteiten i .v.m. administratie, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

MED@ CONSULTING

Warning lights

Financials

What happened to MED@ CONSULTING?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions